British American Tobacco files Indian patent application for filter additive; patent filed on Dec. 7, 2012

NEW DELHI , May 28, 2014 () – UK based British American Tobacco (Investments) Ltd filed patent application for filter additive. The inventors are Sampson John and Rushforth David.

British American Tobacco (Investments) Ltd filed the patent application on Dec. 7, 2012. The patent application number is 10262/CHENP/2012 A. The international classification numbers are A24D3/02 and A24D3/04.

According to the Controller General of Patents, Designs & Trade Marks, "The present invention relates to a method of producing a filter element for inclusion in a smoking article the method comprising applying an additive to filter material the additive being solid at room temperature and the method involving heating the additive so that it melts."

About the Company

British American Tobacco p.l.c. is a global tobacco company headquartered in London, United Kingdom.It is quoted tobacco company by global market share (after Philip Morris International), with a leading position in more than 50 countries and a presence in more than 180 countries.Its brands include Dunhill, Kent, Lucky Strike and Pall Mall. The company was formed in 1902, when the United Kingdom's Imperial Tobacco Company and the American Tobacco Company of the USA agreed to form a joint venture, the British-American Tobacco Co Ltd The parent companies agreed not to trade in each other's domestic territory and to assign trademarks, export businesses and overseas subsidiaries to the joint venture. James 'Buck' Duke became its chairman and the British American Tobacco business began life in countries as diverse as Canada, China, Germany, South Africa, New Zealand and Australia, but not in the United Kingdom or USA.

Copyright Contify.com

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.